| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William K. Heiden | Director | 2025-08-20 | 49,500 | $1.49 | $73.76kBuy |
| William K. Heiden | Director | 2025-08-19 | 50,500 | $1.52 | $76.76kBuy |
| Stephen L. Eck | Chief Medical Officer | 2025-02-15 | 4,942 | $2.56 | $12.65kSell |
| Jeffrey Stuart Peters | Senior VP and General Counsel | 2025-02-15 | 5,147 | $2.56 | $13.18kSell |
| James Karrels | SVP CFO and Secretary | 2025-02-15 | 5,790 | $2.56 | $14.82kSell |
| Thomas Spitznagel | Sr VP Technical Ops | 2025-02-15 | 5,520 | $2.56 | $14.13kSell |
| Beth Ann Smith | VP Controller Treasurer | 2025-02-15 | 423 | $2.56 | $1.08kSell |
| Eric Blasius Risser | Chief Operating Officer | 2025-02-15 | 6,433 | $2.56 | $16.47kSell |
| Jeffrey Stuart Peters | Senior VP and General Counsel | 2025-02-08 | 3,475 | $2.60 | $9.04kSell |
| Stephen L. Eck | Chief Medical Officer | 2025-02-08 | 3,312 | $2.60 | $8.61kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Target N. V. Biotech | 15.71% | 9,929,963 | $18.27M | Insider |
| Bellevue Group Ag | 15.69% | 9,919,992 | $18.25M | Institution |
| Armistice Capital LLC | 9.43% | 5,960,000 | $10.97M | Institution |
| Vanguard Group Inc | 6.67% | 4,213,114 | $7.75M | Institution |
| Wasatch Advisors LP | 5.14% | 3,251,022 | $5.98M | Institution |
| Frazier Life Sciences Management LP | 5.02% | 3,175,665 | $5.84M | Institution |
| Acadian Asset Management LLC | 3.94% | 2,491,703 | $4.58M | Institution |
| Tpg Group Holdings Sbs Advisors Inc | 3.49% | 2,208,762 | $4.06M | Insider |
| Scott Koenig | 3.37% | 2,128,919 | $3.92M | Insider |
| Millennium Management LLC | 3.19% | 2,015,864 | $3.71M | Institution |